Last checked at 21 Sep 2017 17:29
The following amendment has been made to the Director/PDMR Shareholding announcement released on 14 September 2017 at 5.30 p.m. under RNS number 8203Q.
In the previous version of the announcement, the number of nil-cost options awarded to Stephen Wilson under the Performance Share Plan was incorrectly stated to be 38,221 shares; the correct figure of 33,443 shares is now shown.
All other details remain unchanged, and the full amended announcement is shown below.
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that yesterday conditional nil-cost share options were granted under the Genus 2014 Performance Share Plan over ordinary shares in Genus to the Executive Directors and members of the Genus Executive Leadership Team ('GELT') as listed in table A below. In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ending 30 June 2017, nil-cost share options were granted over ordinary shares under Genus's Deferred Share Bonus Plan as listed in table B below.
Details of the performance conditions that apply to the nil-cost share options can be found in the Directors' Remuneration Report of the Genus 2017 Annual Report.
The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the nil-cost share option awards made on 13 September 2017.
For further information please contact:
Genus:
Cara Crichton, Deputy Company Secretary Tel: +44 (0)1256 347100
Table A - GELT 2014 Performance Share Plan Options
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||||||||||||
a. | Name | 1. Karim Bitar 2. Stephen Wilson 3. Bill Christianson 4. Nate Zwald 5. Jerry Thompson 6. Jonathan Lightner 7. Angelle Rosata 8. Dan Hartley | ||||||||||||||||||
2. | Reason for the notification | |||||||||||||||||||
a. | Position/status | 1. Chief Executive 2. Group Finance Director 3. Chief Operating Officer Genus PIC 4. Chief Operating Officer Genus ABS Dairy 5. Chief Operating Officer Genus ABS Beef 6. Chief Scientific Officer & Head of Genus R&D 7. Group Human Resources Director 8. Group General Counsel & Company Secretary | ||||||||||||||||||
b. | Initial notification /Amendment
| Initial notification | ||||||||||||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||||
a. | Name | Genus plc | ||||||||||||||||||
b. | LEI | 54930022EOITNKSIGH56 | ||||||||||||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||||||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 10p each.
GB0002074580 | ||||||||||||||||||
b. | Nature of the transaction | Award of nil-cost share options granted under the Genus plc 2014 Performance Share plan over ordinary shares in Genus.
| ||||||||||||||||||
c. | Price(s) and volume(s) | Numbers 1 to 8 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
| ||||||||||||||||||
d. | Aggregated information · Aggregated volume · Price
|
n/a
| ||||||||||||||||||
e. | Date of the transaction | 2017-09-13 | ||||||||||||||||||
f. | Place of the transaction | London Stock Exchange, Main Market (XLON)
| ||||||||||||||||||
Table B - GELT Deferred Share Bonus Plan Options
1. | Details of the person discharging managerial responsibilities / person closely associated | |
a. | Name | 1. Karim Bitar 2. Stephen Wilson 3. Bill Christianson 4. Nate Zwald 5. Jerry Thompson 6. Jonathan Lightner 7. Dan Hartley |
2. | Reason for the notification | |||||||||||||||||
a. | Position/status | 1. Chief Executive 2. Group Finance Director 3. Chief Operating Officer Genus PIC 4. Chief Operating Officer Genus ABS Dairy 5. Chief Operating Officer Genus ABS Beef 6. Chief Scientific Officer & Head of Genus R&D 7. Group General Counsel & Company Secretary | ||||||||||||||||
b. | Initial notification /Amendment | Initial notification | ||||||||||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||
a. | Name | Genus plc | ||||||||||||||||
b. | LEI | 54930022EOITNKSIGH56 | ||||||||||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||||||
a. | Description of the Financial instrument, type of instrument Identification code | Ordinary shares of 10p each.
GB0002074580 | ||||||||||||||||
b. | Nature of the transaction | Award of nil-cost share options granted under Genus's Deferred Share Bonus Plan following the compulsory deferral of 25% of annual bonus in respect of bonuses earned in the financial year ending 30 June 2017.
| ||||||||||||||||
c. | Price(s) and volume(s) | Numbers 1 to 7 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
| ||||||||||||||||
d. | Aggregated information · Aggregated volume · Price
|
n/a | ||||||||||||||||
e. | Date of the transaction | 2017-09-13 | ||||||||||||||||
f. | Place of the transaction | London Stock Exchange, Main Market (XLON)
| ||||||||||||||||